Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Allergy and Immunology

Living with Hives: Tracking Your Path to Control

At a Glance

To gain complete control over chronic hives, patients should use objective tracking tools like the Urticaria Activity Score 7 (UAS7) and the Urticaria Control Test (UCT). Sharing these daily scores with your doctor takes the guesswork out of adjusting your treatment plan until you reach remission.

Living with chronic hives is a marathon, not a sprint. The most difficult part for many patients is the “unpredictability factor”—the morning ritual of checking the mirror to see if today is a “good skin day” or a “flare day.” While the condition can be exhausting, you are not powerless. By using objective tracking tools, you can take the guesswork out of your appointments and provide your doctor with the data needed to reach complete control [1][2]. (See the Stepwise Treatment Plan to understand how this goal is reached).

The Power of Your Data: UAS7 and UCT

In the world of chronic urticaria, “feeling a bit better” isn’t a precise enough goal. Doctors use two specific tools to decide when it’s time to change your treatment [3][4].

1. The UAS7 (Urticaria Activity Score 7)

The UAS7 is a 7-day diary that measures the “volume” of your disease. Every day for one week, you give yourself a score for two things [5][3]:

  • Hives (0–3): 0 = none; 1 = mild (<20 hives); 2 = moderate (20–50 hives); 3 = intense (>50 hives or large confluent areas).
  • Itch (0–3): 0 = none; 1 = mild; 2 = moderate; 3 = intense (interferes with sleep or daily activity).

Your daily score is out of 6. At the end of the week, you have a total score out of 42.

  • Score 0: Remission (The Goal) [2].
  • Score 1–6: Well-controlled disease.
  • Score 7–15: Mild activity.
  • Score 16–27: Moderate activity.
  • Score 28–42: Severe activity [6][7].

2. The UCT (Urticaria Control Test)

While the UAS7 looks at the last week, the UCT looks at the last four weeks. It is a quick, 4-question test that asks how much your hives have affected your quality of life and how well your current treatment is working [8].

  • The Threshold: A total score of 12 or higher means your disease is well-controlled. A score of 11 or lower is a clear signal to your doctor that your current treatment is not enough and needs to be “stepped up” [9][10].

The Mental Toll of Unpredictability

It is medically recognized that chronic hives carry a significant psychological burden. The constant “itch-scratch” cycle and the lack of a visible trigger often lead to [11][12]:

  • Anxiety and Depression: Rates are significantly higher in CU patients than in the general population [11].
  • Sleep Deprivation: Because hives often peak at night, poor sleep quality is a common complication that worsens emotional well-being [13][14].
  • Stress Styles: Emotional stress can act as a “multiplier,” making the physical itch feel more intense [15][16].

Long-Term Outlook

For most patients, chronic spontaneous urticaria is a self-limiting condition that eventually goes into remission [17]. While it can last for several years (average 2–5), the goal of modern medicine is to keep you symptom-free with minimal side effects until the condition fades on its own [18][1]. Return to the Home Page to review the basics.

Daily Strategy: Beyond medication, many patients find stability by maintaining a consistent routine, avoiding known physical irritants (like very hot showers or tight elastic waistbands), and using the UAS7 to identify if specific stressors correlate with their flares [15]. Providing this objective diary to your specialist is the most effective way to advocate for the treatment you need to reach a score of zero.

Common questions in this guide

What is a UAS7 score for chronic hives?
The Urticaria Activity Score 7 (UAS7) is a daily diary used to track the volume of your hives and the intensity of your itch over a one-week period. Your daily score is out of 6, creating a total weekly score out of 42 to help your doctor objectively measure disease severity.
What does a UCT score mean for my treatment?
The Urticaria Control Test (UCT) evaluates how well your current treatment is working and how hives affect your quality of life over the last four weeks. A total score of 11 or lower indicates that your disease is not well-controlled and your treatment may need to be stepped up.
How long do chronic spontaneous hives last?
For most patients, chronic spontaneous urticaria is a self-limiting condition that eventually goes into remission on its own. While it can last an average of 2 to 5 years, modern treatments aim to keep you completely symptom-free until the condition fades.
Can stress and anxiety make my chronic hives worse?
Yes, emotional stress can act as a multiplier, making the physical itch feel more intense. Chronic hives can also cause a significant psychological burden, leading to anxiety, sleep deprivation, and depression due to the unpredictability of flares.
How do I know if my chronic hives are fully controlled?
Complete control is the ultimate goal of treatment, which means reaching a score of zero on the UAS7 tracker. If you consistently have a score above zero, you should discuss your diary with your doctor to see if your medication needs adjusting.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my current UAS7 score, are we meeting our 'treat-to-target' goal of complete control?
  2. 2.At what UAS7 or UCT score threshold should we consider moving to the next step in the treatment guideline?
  3. 3.Can you recommend any psychological support or stress-management resources that are specifically tailored for patients with chronic conditions?
  4. 4.Is there a specific 'rescue' plan I should follow if I have a sudden flare that significantly increases my daily score?
  5. 5.What is the long-term plan for 'stepping down' my medication once we achieve a sustained score of zero?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    The Classification, Pathogenesis, Diagnostic Workup, and Management of Urticaria: An Update.

    Maurer M, Zuberbier T, Metz M

    Handbook of experimental pharmacology 2022; (268()):117-133 doi:10.1007/164_2021_506.

    PMID: 34247278
  2. 2

    Management of chronic spontaneous urticaria (CSU): a treat to target approach using a patient reported outcome.

    Lima H, Gooderham M, Dutz J, et al.

    Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2017; (13()):38 doi:10.1186/s13223-017-0210-0.

    PMID: 28852410
  3. 3

    The Arabic Urticaria Activity Score and Chronic Urticaria Quality of Life Questionnaire: validation and correlations.

    Tawil S, Irani C, Kfoury R, et al.

    International journal of dermatology 2020; (59(8)):893-901 doi:10.1111/ijd.15006.

    PMID: 32638368
  4. 4

    Expert opinion: defining response to omalizumab in patients with chronic spontaneous urticaria.

    Ferrer M, Boccon-Gibod I, Gonçalo M, et al.

    European journal of dermatology : EJD 2017; (27(5)):455-463 doi:10.1684/ejd.2017.3085.

    PMID: 29084635
  5. 5

    Cost-effective omalizumab dosage for chronic urticaria: a systematic review and network meta-analysis.

    Tajerian A, Pourvali A, Khoshkhui M, et al.

    Archives of dermatological research.. 2024; (317(1)):131 doi:10.1007/s00403-024-03629-2.

    PMID: 39673624
  6. 6

    EQ-5D Utilities in Chronic Spontaneous/Idiopathic Urticaria.

    Hawe E, McBride D, Balp MM, et al.

    PharmacoEconomics 2016; (34(5)):521-7 doi:10.1007/s40273-015-0375-7.

    PMID: 26792790
  7. 7

    Global Real-World Validation of First-Day Urticaria Activity Score (UAS1).

    Su LH, Sousa Pinto B, Ramanauskaite A, et al.

    The journal of allergy and clinical immunology. In practice 2026; (14(7)):1663-1670.e7 doi:10.1016/j.jaip.2026.04.011.

    PMID: 42019723
  8. 8

    Omalizumab in patients with chronic spontaneous urticaria nonresponsive to H1-antihistamine treatment: results of the phase IV open-label SUNRISE study.

    Bérard F, Ferrier Le Bouedec MC, Bouillet L, et al.

    The British journal of dermatology 2019; (180(1)):56-66 doi:10.1111/bjd.16904.

    PMID: 29927483
  9. 9

    Disease Control, Activity and Quality of Life in Chronic Spontaneous Urticaria: A Cross-Sectional Study from Kazakhstan.

    Batyrbayeva A, Ispayeva Z, Pashimov M, et al.

    Diagnostics (Basel, Switzerland) 2026; (16(5)) doi:10.3390/diagnostics16050672.

    PMID: 41827948
  10. 10

    Health-Related Utility of EQ-5D in Korean Adults With Chronic Urticaria: Mapping From Urticaria Outcome Measures.

    Lee MS, Yoon J, Kim J, et al.

    Allergy, asthma & immunology research 2020; (12(4)):599-607 doi:10.4168/aair.2020.12.4.599.

    PMID: 32400127
  11. 11

    Does chronic urticaria affect quality of sleep and quality of life?

    Abdel-Meguid AM, Awad SM, Noaman M, et al.

    Journal of public health research 2024; (13(2)):22799036241243268 doi:10.1177/22799036241243268.

    PMID: 38638409
  12. 12

    Association of Chronic Urticaria with Psychological Distress: A Multicentre Cross-sectional Study.

    Tawil S, Irani C, Kfoury R, et al.

    Acta dermato-venereologica 2023; (103()):adv00865 doi:10.2340/actadv.v102.2939.

    PMID: 36129251
  13. 13

    Sleep Disturbance and Chronic Urticaria: A Narrative Review of Its Relationship, Treatment and Evolving Literature.

    Wasim AU, Miriyala SA, Haward R, et al.

    Health science reports 2025; (8(5)):e70777 doi:10.1002/hsr2.70777.

    PMID: 40330757
  14. 14

    Relationships between quality of life, sleep problems, and sleep quality in patients with chronic idiopathic urticaria.

    Ates H, Firat S, Buhari GK, et al.

    Journal of cosmetic dermatology 2022; (21(9)):4072-4079 doi:10.1111/jocd.14851.

    PMID: 35166020
  15. 15

    Can the Control of Chronic Spontaneous Urticaria Symptoms Depend on the Stress-Coping Styles?

    Pluta-Kubicz M, Jura-Szołtys E, Gawlik R, et al.

    Diagnostics (Basel, Switzerland) 2025; (15(23)) doi:10.3390/diagnostics15232965.

    PMID: 41374346
  16. 16

    Anxiety, depression, and stress in Korean patients with chronic urticaria.

    Choi GS, Nam YH, Park CS, et al.

    The Korean journal of internal medicine 2020; (35(6)):1507-1516 doi:10.3904/kjim.2019.320.

    PMID: 32450676
  17. 17

    Chronic Spontaneous Urticaria: The Devil's Itch.

    Saini SS, Kaplan AP

    The journal of allergy and clinical immunology. In practice 2018; (6(4)):1097-1106 doi:10.1016/j.jaip.2018.04.013.

    PMID: 30033911
  18. 18

    The future of targeted therapy in chronic spontaneous urticaria.

    Min TK, Saini SS

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2024; (133(4)):367-373 doi:10.1016/j.anai.2024.05.020.

    PMID: 38885835

This page is for informational purposes only and does not replace professional medical advice. Always discuss your UAS7 or UCT symptom trackers with your allergist or dermatologist to guide your specific treatment plan.

Get notified when new evidence is published on chronic urticaria.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.